In the News story “Japan jumps towards personalized medicine” (Nature 437, 796; 200510.1038/437796b), the description of aminoglycosides, drugs that can cause ear damage in people with a certain genetic mutation, was wrongly attributed to the cancer drug irinotecan. Both are candidates for Japan's efforts to create personalized medicine as described in the article. Nature wishes to apologize for the confusion.
Contrary to a statement in the Editorial “Responding to uncertainty” (Nature 437, 1; 200510.1038/437001a), there is no evidence that lives have been lost as a result of the significant dip in take-up in Britain of the triple vaccine for measles, mumps and rubella.
Additional information
The online version of the original article can be found at 10.1038/437796b
Rights and permissions
About this article
Cite this article
Corrections. Nature 437, 1079 (2005). https://doi.org/10.1038/4371079a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4371079a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.